Meyka Pro banner
WuXi XDC Cayman Inc

WuXi XDC Cayman Inc Fundamental Analysis (HKSE: 2268.HK)

2268.HKHKSE
HealthcareMedical - Diagnostics & Research
HK$77.25
HK$7.45(10.67%)
Hong Kong Market opens in 5h 42m

WuXi XDC Cayman Inc Fundamental Analysis (HKSE: 2268.HK)

WuXi XDC Cayman Inc (HKSE: 2268.HK) shows moderate financial fundamentals with a PE ratio of 56.29, profit margin of 22.36%, and ROE of 14.00%. The company generates $6.9B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Operating Margin27.69%
Current Ratio2.37

Areas of Concern

PEG Ratio2.99
We analyze 2268.HK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 74.0/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B
74.0/100

We analyze 2268.HK's fundamental strength across five key dimensions:

Efficiency Score

Weak

2268.HK struggles to generate sufficient returns from assets.

ROA > 10%
9.93%

Valuation Score

Weak

2268.HK trades at a premium to fair value.

PE < 25
56.29
PEG Ratio < 2
2.99

Growth Score

Moderate

2268.HK shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

2268.HK maintains a strong and stable balance sheet.

Debt/Equity < 1
0.05
Current Ratio > 1
2.37

Profitability Score

Moderate

2268.HK maintains healthy but balanced margins.

ROE > 15%
14.00%
Net Margin ≥ 15%
22.36%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is 2268.HK Expensive or Cheap?

P/E Ratio

2268.HK trades at 56.29 times earnings. This suggests a premium valuation.

56.29

PEG Ratio

When adjusting for growth, 2268.HK's PEG of 2.99 indicates potential overvaluation.

2.99

Price to Book

The market values WuXi XDC Cayman Inc at 7.65 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

7.65

EV/EBITDA

Enterprise value stands at 41.76 times EBITDA. This signals the market has high growth expectations.

41.76

How Well Does 2268.HK Make Money?

Net Profit Margin

For every $100 in sales, WuXi XDC Cayman Inc keeps $22.36 as profit after all expenses.

22.36%

Operating Margin

Core operations generate 27.69 in profit for every $100 in revenue, before interest and taxes.

27.69%

ROE

Management delivers $14.00 in profit for every $100 of shareholder equity.

14.00%

ROA

WuXi XDC Cayman Inc generates $9.93 in profit for every $100 in assets, demonstrating efficient asset deployment.

9.93%

Following the Money - Real Cash Generation

Operating Cash Flow

WuXi XDC Cayman Inc generates strong operating cash flow of $1.83B, reflecting robust business health.

$1.83B

Free Cash Flow

WuXi XDC Cayman Inc produces free cash flow of $575.01M, offering steady but limited capital for shareholder returns and expansion.

$575.01M

FCF Per Share

Each share generates $0.45 in free cash annually.

$0.45

FCF Yield

2268.HK converts 0.66% of its market value into free cash.

0.66%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

56.29

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

2.99

vs 25 benchmark

P/B Ratio

Price to book value ratio

7.65

vs 25 benchmark

P/S Ratio

Price to sales ratio

12.62

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.37

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.14

vs 25 benchmark

ROA

Return on assets percentage

0.10

vs 25 benchmark

ROCE

Return on capital employed

0.16

vs 25 benchmark

How 2268.HK Stacks Against Its Sector Peers

Metric2268.HK ValueSector AveragePerformance
P/E Ratio56.2932.14 Worse (Expensive)
ROE14.00%550.00% Weak
Net Margin22.36%30133.00% Weak
Debt/Equity0.050.56 Strong (Low Leverage)
Current Ratio2.375.70 Strong Liquidity
ROA9.93%3.00% Excellent

2268.HK outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROA, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews WuXi XDC Cayman Inc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ